StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$56.30+1.31 (+2.38%)

Close on Nov 17, 2026Market cap $7.34BP/E –Yield –

10x Genomics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

10x Genomics's market cap was $7.93B on Nov 11, 2026, against $2.32B a year earlier. Over the last 5 years it ranged from $1.01B to $16.27B, with a median of $4.12B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.93B+293.3%
2025Dec 31, 2025$2.02B+17.2%
2024Dec 31, 2024$1.72B-73.6%
2023Dec 29, 2023$6.50B+57.7%
2022Dec 30, 2022$4.12B-74.7%
2021Dec 31, 2021$16.27B+8.8%
2020Dec 31, 2020$14.95B+104.0%
2019Dec 31, 2019$7.33B–

More 10x Genomics figures

See a number that looks wrong?